Back to Search
ROBERT SABO, MD
MD
Neurological Surgery Physician
NPI: 1780733618IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
25MA06562100(NJ)
CMS Specialties
PrimaryNEUROSURGERY
Education
JEFFERSON MEDICAL COLLEGE OF THOMAS JEFFERSON UNIVERSITY
Class of 1990
Research & Publications (18)
Cytotoxic effect of mistletoe (Viscum album L.) extract on Jurkat cells and its interaction with doxorubicin.
PMID 19610041·Phytother Res·2010
8-other
Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes.
PMID 19364302·Curr Med Res Opin·2009
2-rct
Induction of micronuclei in rat bone marrow after chronic exposure to lead acetate trihydrate.
PMID 19106125·Toxicol Ind Health·2008
7-preclinical
Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
PMID 17986525·J Clin Pharmacol·2008
2-rct
The effect of age, gender, and body mass index on the pharmacokinetics and pharmacodynamics of vildagliptin in healthy volunteers.
PMID 17961192·Br J Clin Pharmacol·2008
4-observational
The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin.
PMID 17486328·Eur J Clin Pharmacol·2007
3-trial
The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
PMID 17713976·Clin Pharmacokinet·2007
2-rct
Evaluation of pharmacokinetic interactions between vildagliptin and digoxin in healthy volunteers.
PMID 17660482·J Clin Pharmacol·2007
2-rct
Dose proportionality and the effect of food on vildagliptin, a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers.
PMID 17656620·J Clin Pharmacol·2007
2-rct
Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
PMID 17519080·Curr Med Res Opin·2007
2-rct
Effect of hemodialysis on the thickness of vocal folds: a possible explanation for postdialysis hoarseness.
PMID 16636582·Nephron Clin Pract·2006
8-other
Challenges of managing patients with inherited metabolic disorders in a developing country.
PMID 15906736·Southeast Asian J Trop Med Public Health·2003
8-other
The challenge of emerging surgical technology: the College can help.
PMID 17387985·Bull Am Coll Surg·2002
8-other
Metastatic hypernephroma to the head and neck: unusual case reports and review of the literature.
PMID 11771041·J Otolaryngol·2001
5-case
Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group.
PMID 11103758·Clin Pharmacol Ther·2000
3-trial
Interleukin 10-induced thrombocytopenia in normal healthy adult volunteers: evidence for decreased platelet production.
PMID 11091188·Br J Haematol·2000
3-trial
A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group.
PMID 10960463·Hepatology·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 110 HARBOR LANE
SOMERS POINT, NJ 08244 - Phone
- (609) 653-9110
Quick Facts
- NPI
- 1780733618
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 18
Are you this provider?
Claim Your Profile